Orthopedic imaging relies on X-ray, MRI and CT to diagnose disorders and injuries affecting the bones, muscles, ligaments, tendons, cartilage, and spine. Orthopedists also use these test results to create an effective treatment plan.
Genicular artery embolization targets synovial blood vessel abnormalities believed to cause painful inflammation that contributes to the severe discomfort most patients experience with OA.
The goal of the study is to obtain quantitative data on how daily training and competing affect players’ musculoskeletal health. The information will be used to inform training, rest and recovery periods.
Although gadolinium-based contrast agents are largely considered safe and are routinely used for MRI exams, experts suggest that providers should still utilize GBCAs sparingly for musculoskeletal studies.
Genicular artery embolization targets synovial blood vessel abnormalities believed to cause painful inflammation that contributes to the severe discomfort most patients experience with OA.
The goal of the study is to obtain quantitative data on how daily training and competing affect players’ musculoskeletal health. The information will be used to inform training, rest and recovery periods.
Although gadolinium-based contrast agents are largely considered safe and are routinely used for MRI exams, experts suggest that providers should still utilize GBCAs sparingly for musculoskeletal studies.
In PRF procedures, a probe is used to intermittently apply energy directly to the dorsal root ganglia, which is often where pain and neurologic symptoms associated with sciatica originate.
The newly approved PET radiotracer is expected to improve patient care significantly. “We have been able to reach the pinnacle of myocardial perfusion imaging with flurpiridaz," one expert said.
GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.
Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.